Clinical Managment and Trials Core and Advocacy Sub-Core

临床管理和试验核心和宣传子核心

基本信息

批准号：
7962152
负责人：
SELWYN M VICKERS
金额：
$ 25.89万
依托单位：
UNIVERSITY OF ALABAMA AT BIRMINGHAM
依托单位国家：
美国
项目类别：
财政年份：
2010
资助国家：
美国
起止时间：
2010-03-01 至 2015-02-28
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7962152
关键词：
Advocacy Alabama Awareness Basic Science Bioethics Cancer Center Clinic Clinical Clinical Management Clinical Pathways Clinical Protocols Clinical Trials Communities Community Health Education Comprehensive Cancer Center Data Collection Databases Development Enrollment Facility Accesses Family Goals Health Services Accessibility Health Services Research Instruction Joints Leadership Link Liver Malignant neoplasm of pancreas Medical center Minnesota Minority Nebraska Newsletter Pancreas Patient Care Patient Care Management Patients Physicians Play Protocols documentation Registries Reproduction spores Research Infrastructure Research Personnel Research Project Grants Role Serum Services Site Support Groups Tissues Translations Universities Urine Work anticancer research cancer Biomedical Informatics Grid clinical care gastrointestinal medical schools molecular pathology multidisciplinary oncology prospective tissue resource web site

项目摘要

PROJECT SUMMARY (See instructions): The overall purpose of the Clinical Management and Trials Core of the UAB/UMN SPORE in Pancreatic Cancer is to provide a coordinated infrastructure and expertise at both sites to support SPORE investigators in translation of their mature basic science ideas into clinical protocols. This will be accomplished through the following speciflc aims: (1) To provide a comprehensive, multi-disciplinary, patient care clinical pathway for all patients with pancreatic cancer. (2) To facilitate the clinical translation of SPORE major projects. (3) To establish the Joint UAB/UMN Pancreatic Cancer Clinical Database (PCCD), as a caBIG compliant database which can then be linked to the Pancreatic Cancer Collaborative Registry (PCCR) at the University of Nebraska. (4) To provide and coordinate with the Tissue Resource and Molecular Pathology Core (Tissue Core) the acquisition of urine, serum, and tissue according to the existing clinical protocol and in support of SPORE projects. (5) To provide referring physicians, patients, and the public with information regarding pancreatic cancer research and clinical protocols available at UAB and UMN Comprehensive Cancer Centers, other Pancreatic SPORES, the national Pancreas Cancer Collaborative Registry (PCCR), and other Medical Centers via newsletter, web sites, and the Community Advocacy Board. (6) To provide the opportunity for minority Investigator inclusion and participation in clinical trial development through continued partnerships with the Morehouse School of Medicine and Tuskegee University, and with the assistance of the Facility for Access to Clinical Enrollment Services (FACES) of the UAB Comprehensive Cancer Center (CCC) and the National Center for Bioethics in Research and Healthcare at Tuskegee. The Core will be directed by Dr. Selwyn M. Vickers who will provide overall leadership and administration of the Core, along with the leadership of Co-Director Dr. C. Mel Wilcox, in coordination among its essential components including the UAB Multidisciplinary Gastrointestinal Oncology Clinic (MDGI) and the UMN Pancreas and Liver Center (PLC). In addition the Advocacy Sub-Core will play an integral role through involvement with the pancreatic cancer support group, patient and family education, and community awareness for pancreatic cancer.

项目摘要（参见说明）： UAB/UMN SPORE 胰腺临床管理和试验核心的总体目的 Cancer 将在两个地点提供协调的基础设施和专业知识来支持 SPORE 研究人员将其成熟的基础科学理念转化为临床方案。这将是通过以下具体目标来实现： (1) 提供全面的、多学科的、所有胰腺癌患者的患者护理临床路径。 (2) 促进临床转化 SPORE重大项目。 (3) 建立UAB/UMN联合胰腺癌临床数据库(PCCD)，作为符合 caBIG 的数据库，然后可以链接到胰腺癌合作登记处 (PCCR) 在内布拉斯加大学。 (4) 提供组织资源并与之协调分子病理学核心（组织核心）根据分子病理学核心（组织核心）采集尿液、血清和组织现有的临床方案并支持 SPORE 项目。 (5) 为转诊医生、患者、以及公众可在以下网址获取有关胰腺癌研究和临床方案的信息： UAB 和 UMN 综合癌症中心、其他胰腺 SPORES、国家胰腺癌中心协作登记处 (PCCR) 和其他医疗中心通过时事通讯、网站和社区宣传委员会。 (6) 为少数研究者纳入和参与研究提供机会通过与莫尔豪斯医学院的持续合作进行临床试验开发塔斯基吉大学，并在获得临床注册服务设施的协助下 UAB 综合癌症中心 (CCC) 和国家生物伦理中心 (FACES) 塔斯基吉的研究和医疗保健。核心将由 Selwyn M. Vickers 博士领导，他将在联合主任 C. C. 博士的领导下，提供核心的全面领导和管理。 Mel Wilcox，协调其重要组成部分，包括 UAB 多学科胃肠肿瘤诊所 (MDGI) 和 UMN 胰腺和肝脏中心 (PLC)。此外倡导子核心将通过参与胰腺癌支持发挥不可或缺的作用团体、患者和家庭教育以及社区对胰腺癌的认识。